chalcone has been researched along with Bright Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, K; Honda, S; Nagamatsu, T; Suzuki, Y | 2 |
2 other study(ies) available for chalcone and Bright Disease
| Article | Year |
|---|---|
Butein ameliorates experimental anti-glomerular basement membrane (GBM) antibody-associated glomerulonephritis in rats (1).
Topics: Animals; Antibodies, Heterophile; Basement Membrane; Chalcone; Chalcones; Cholesterol; Glomerulonephritis; Immunoglobulin G; Kidney Glomerulus; Leukocytes; Male; Proteinuria; Rabbits; Rats; Rats, Sprague-Dawley | 1996 |
Butein (3,4,2',4'-tetrahydroxychalcone) ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis (3).
Topics: Animals; Cell Membrane; Chalcone; Chalcones; Dose-Response Relationship, Drug; Glomerulonephritis; Humans; Male; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Umbilical Veins | 1996 |